Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Velano Vascular has secured $10 million as the initial tranche of a growth financing to fuel commercialization and the launch of new vascular access solutions. But perhaps most telling about this funding news is the notable investors who kic

Schaffhausen, Switzerland-based Physeon is trying to bring its Veinplicity device to the U.S. market. The device is designed to make veins easier to access on the first stick, preventing patients from being treated as pincushions.

Atellica Solution Immunoassay Clinical Chemistry Analyzers Atellica Solution is a multi analyzer system for in vitro diagnostic testing of clinical specimens. It offers unprecedented flexibility with over 300 configurations. Components can

Point-of-care (POC) testing is a rapidly growing market. As healthcare starts to shift toward consumers, the demand for tests that can be performed anywhere the patient is located, is increasing. With the promise to reduce costs and give qui

A November 2018 FDA inspection has resulted in a warning letter for Zeller Power Products. The Wallace, ID-based company makes a replacement battery for Cardiac Science's PowerHeart Automated External Defibrillator (AED) G3.

Robotics in medtech are quickly becoming common place as the number of companies in the market continue to grow. On June 12, seasoned veterans of robotic surgery companies will share their thoughts about the state of surgical robotics techno

Grail has hit a major milestone as the liquid biopsy company is reporting it has been granted Break Through Device Designation by FDA. The Menlo Park, CA-based company is developing an investigational next-generation sequencing (NGS) blood t

Illumina and the Childrens Hospital of Fudan University in China plan to launch a study of whole-genome sequencing in the hospitals neonatal intensive care unit to determine whether it can be used as a diagnostic for critically ill infants,

To understand the impact of genomic structural variation on human disease, GrandOmics, a leading domestic sequencing company, announced a large-scale sequencing project called dbSV-100K.The project aims to use high-throughput nanopore sequen

Recently, Kehua Biotech released the first quarter report of 2019. During the reporting period, the company realized the main business income of 506 million yuan, an increase of 11.8%; the net profit attributable to shareholders of listed co